Search - tctmd.com

Displaying 1 - 15 of 15

Sort: Relevancy | Date

News Features

Weight-Loss Showdown: Is It Time for an RCT of Bariatric Surgery vs GLP-1s?

Michael O'Riordan

January 17, 2025

News Features

After DanGer Shock’s Win in AMICS for Impella: What’s Next?

Caitlin E. Cox

May 02, 2024

News Features

Pricey Inclisiran Is Rolling Out: a ‘Buy-and-Bill’ Model May Smooth Its Path

Michael O'Riordan

January 17, 2022

News Features

FFR’s Future: Negative Trials Spur Debate Over Technology’s Role

Michael O'Riordan

December 23, 2021

News Features

Cath Lab Teams Find Enduring Lessons in COVID-19’s Unending Reign

L.A. McKeown

December 20, 2021

News Features

As COVID-19 Drags on, the Cardiology Fallout May Haunt for Years

Caitlin E. Cox

December 16, 2021

News Features

World-wise: As In-Person Meetings Resume, Global Voices Hope to Be Heard

Shelley Wood

December 13, 2021

News Features

Home School: Clinical Trials Went Virtual in COVID-19—Are They Here to Stay?

Todd Neale

December 09, 2021

News Features

US Chest Pain Guidelines Will Change Practice, Though Gaps Remain

Yael L. Maxwell

December 06, 2021

News Features

The Right Anticoagulation Dose in COVID-19? Final Answer Remains Elusive

Todd Neale

February 08, 2021

News Features

Hydroxychloroquine: No Help, Clear Harm in COVID-19 RCT and Cohort Studies

Shelley Wood

May 20, 2020

News Features

‘Salvage What We Can’: Cardiology Clinical Trials in Turmoil Amid COVID-19

Michael O'Riordan

April 07, 2020

News Features

Year in Review: Endovascular Saw Paclitaxel Storm Rage, CLI Care Advance in 2019

L.A. McKeown

December 12, 2019

News Features

Wearables Under the Microscope: How New Tech Will Disrupt Patient-Physician Dynamics

Marcus A. Banks

August 15, 2019

News Features

To RCT or Not to RCT? Impella Debate Pivots on How Best to Study Patients on the Brink of Death

Caitlin E. Cox

May 02, 2018

Advertisement

Weight-Loss Showdown: Is It Time for an RCT of Bariatric Surgery vs GLP-1s?

After DanGer Shock’s Win in AMICS for Impella: What’s Next?

Pricey Inclisiran Is Rolling Out: a ‘Buy-and-Bill’ Model May Smooth Its Path

FFR’s Future: Negative Trials Spur Debate Over Technology’s Role

Cath Lab Teams Find Enduring Lessons in COVID-19’s Unending Reign

As COVID-19 Drags on, the Cardiology Fallout May Haunt for Years

World-wise: As In-Person Meetings Resume, Global Voices Hope to Be Heard

Home School: Clinical Trials Went Virtual in COVID-19—Are They Here to Stay?

US Chest Pain Guidelines Will Change Practice, Though Gaps Remain

The Right Anticoagulation Dose in COVID-19? Final Answer Remains Elusive

Hydroxychloroquine: No Help, Clear Harm in COVID-19 RCT and Cohort Studies

‘Salvage What We Can’: Cardiology Clinical Trials in Turmoil Amid COVID-19

Year in Review: Endovascular Saw Paclitaxel Storm Rage, CLI Care Advance in 2019

Wearables Under the Microscope: How New Tech Will Disrupt Patient-Physician Dynamics

To RCT or Not to RCT? Impella Debate Pivots on How Best to Study Patients on the Brink of Death

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content